GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,378.20p
   
  • Change Today:
      3.00p
  • 52 Week High: 2,253.25
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.99m
  • Volume: 1,528,384
  • Market Cap: £56,437m
  • RiskGrade: 129

Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian
GlaxoSmithKline's mulled HIV spin-off 'bigger th... 23-Oct-2014 Telegraph
GlaxoSmithKline shares rise after drugs giant pl... 23-Oct-2014 Daily Mail
Glaxo to float its HIV cures as a standalone £15... 23-Oct-2014 The Independent
RBS chairman to head embattled GlaxoSmithKline 26-Sep-2014 Guardian
Royal Bank of Scotland chairman to move to Glaxo... 25-Sep-2014 Guardian
GSK to start production of Ebola vaccine as test... 29-Aug-2014 Guardian
MARKET REPORT: Evotec deal just the tonic for Gl... 28-Aug-2014 Express & Star
GlaxoSmithKline faces fresh drug bribery claims ... 13-Aug-2014 Guardian
Now GlaxoSmithKline faces claims of bribery from... 13-Aug-2014 Daily Mail
GlaxoSmithKline faces fresh bribery allegations ... 13-Aug-2014 The Independent
Peter Humphrey trial: GlaxoSmithKline to blame, ... 08-Aug-2014 Telegraph
GlaxoSmithKline looking to bag RBS chairman Sir ... 08-Aug-2014 Telegraph
Sir Philip Hampton may quit RBS in potential mov... 08-Aug-2014 Guardian
GlaxoSmithKline affirms policy of anti-corruptio... 24-Jul-2014 Guardian
Pained Glaxo sees sales take turn for the worse 24-Jul-2014 Express & Star

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,378.20p
Change Today 3.00p
% Change 0.22 %
52 Week High 2,253.25
52 Week Low 1,296.00
Volume 1,528,384
Shares Issued 4,094.99m
Market Cap £56,437m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.87% below the market average66.87% below the market average66.87% below the market average66.87% below the market average66.87% below the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Price Trend
42.75% below the market average42.75% below the market average42.75% below the market average42.75% below the market average42.75% below the market average
14.75% above the sector average14.75% above the sector average14.75% above the sector average14.75% above the sector average14.75% above the sector average
Income
44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
40.01% below the market average40.01% below the market average40.01% below the market average40.01% below the market average40.01% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

What The Brokers Say

Strong Buy 3
Buy 5
Neutral 14
Sell 1
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 18-May-23 23-Feb-23
Paid 13-Jul-23 13-Apr-23
Amount 14.00p 13.75p

Trades for 09-Jun-2023

Time Volume / Share Price
11:19 108 @ 1,378.10p
11:17 107 @ 1,378.00p
11:17 63 @ 1,378.20p
11:17 238 @ 1,378.40p
11:17 239 @ 1,378.20p

GSK Key Personnel

CEO Emma Walmsley

Top of Page